Page 29 - 台灣肝癌醫學冬季會手冊-1222-V3_Neat

Speaker

Ann-Lii Cheng, MD., PhD

Distinguished professor, NTU Superintendent,

NTU Cancer Center

Ann-Lii Cheng is distinguished professor and Director of the NTU Cancer Center

of National Taiwan University. He received his MD degree, PhD degree, and his

specialty training in internal medicine and medical oncology at the Medical
School of the National Taiwan University. In 1990, he was a research fellow at

the Comprehensive Cancer Center of the University of Wisconsin, Madison,

USA. Dr. Cheng has been actively involved in basic and translational research in
hepatocellular carcinoma and has published more than 300 peer-reviewed articles.

He was elected as Fellow of American Association for the Advancement of

Science
(AAAS) in 2007. He received the national award of “outstanding contributions

for science and technology” in 2008, and a national award for academic

excellence in 2010. He served as president of the Taiwan Oncology Society
during 2009-2011. He was elected as National Chair Professorship in 2013, and

has been the founding director of NTU Cancer Center. He is considered a world

leader in the clinical and translational research of hepatocellular carcinoma, and is
heavily involved in international academic activities. He currently serves as the

president of APPLE (Asia Pacific Primary Liver Cancer Expert) society.